{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:14:26Z","timestamp":1791231266848,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","award":["198168"],"award-info":[{"award-number":["198168"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["14032"],"award-info":[{"award-number":["14032"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejca.2025.116164","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:20:22Z","timestamp":1764980422000},"page":"116164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Surgical stage in the era of molecular profiling of endometrial cancer"],"prefix":"10.1016","volume":"233","author":[{"given":"J.C.","family":"Kasius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Kildal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.W.","family":"Vrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Askautrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"van Altena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-A.R.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Reijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Dackus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vlatkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Huvila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Steinlechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Tubita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gil-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.L.M.","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.","family":"Hveem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Asberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Zeimet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Matias-Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.C.M.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.A.","family":"Pijnenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kleppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejca.2025.116164_bib1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann Oncol"},{"issue":"22","key":"10.1016\/j.ejca.2025.116164_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225848","article-title":"Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification","volume":"13","author":"Kasius","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7447","key":"10.1016\/j.ejca.2025.116164_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ejca.2025.116164_bib4","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol"},{"issue":"29","key":"10.1016\/j.ejca.2025.116164_bib5","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Leon-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2025.116164_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/ijgc-2021-002705","article-title":"Incorporating molecular profiling into endometrial cancer management requires prospective studies","volume":"31","author":"Amant","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2025.116164_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/ijgc-2023-005165","article-title":"Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer","volume":"34","author":"Luzarraga Aznar","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2025.116164_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113584","article-title":"Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer","volume":"200","author":"Lindemann","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.116164_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ygyno.2024.11.005","article-title":"Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer","volume":"192","author":"Kleppe","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2025.116164_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ygyno.2022.01.025","article-title":"Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases","volume":"165","author":"Jamieson","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2025.116164_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2025.116164_bib12","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2023.34.e85","article-title":"FIGO staging of endometrial cancer: 2023","volume":"34","author":"Berek","year":"2023","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116164_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/ijgc-2023-004981","article-title":"FIGO 2023 endometrial cancer staging: too much, too soon?","volume":"34","author":"McCluggage","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2025.116164_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.47372","article-title":"Relevance of molecular profiling in patients with low-grade endometrial cancer","volume":"5","author":"Vrede","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ejca.2025.116164_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2024.101618","article-title":"Real-world outcomes in molecular subgroups for patients with advanced or recurrent endometrial cancer treated with platinum-based chemotherapy","volume":"35","author":"Lindemann","year":"2025","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2025.116164_bib16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2025.116164_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0020-7292(98)00234-3","article-title":"FIGO staging of gynecologic cancer. 1994-1997 FIGO committee on gynecologic oncology. international federation of gynecology and obstetrics","volume":"64","author":"Pecorelli","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejca.2025.116164_bib18","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","volume":"38","author":"Kobel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116164_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12885-020-06785-6","article-title":"Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material","volume":"20","author":"Steeghs","year":"2020","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2025.116164_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas","volume":"250","author":"Leon-Castillo","year":"2020","journal-title":"J Pathol"},{"issue":"13","key":"10.1016\/j.ejca.2025.116164_bib21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/jnci\/djm024","article-title":"Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials","volume":"99","author":"Punt","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.ejca.2025.116164_bib22","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S1470-2045(25)00379-1","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial","volume":"26","author":"Post","year":"2025","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116164_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ijgc-2022-004039","article-title":"Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program","volume":"33","author":"Consortium","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2025.116164_bib24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/ijgc-2020-001822","article-title":"Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy","volume":"31","author":"van den Heerik","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2025.116164_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13000-024-01584-0","article-title":"Prognostic factors and survival outcomes of immunohistochemically detection based-molecular subtypes of endometrial cancer-analysis of 576 clinical cases","volume":"19","author":"Wang","year":"2024","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ejca.2025.116164_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2024.12.014","article-title":"Added prognostic value of sentinel lymph node mapping in endometrial cancer to molecular subgroups","volume":"193","author":"Siegenthaler","year":"2025","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2025.116164_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2024.09.012","article-title":"Lymph node metastases in endometrial carcinoma: A modern assessment in the era of sentinel lymph node mapping and molecular subtyping","volume":"191","author":"Praiss","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2025.116164_bib28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/ijgc-2024-005711","article-title":"SENECA study: staging endometrial cancer based on molecular classification","volume":"34","author":"Chacon","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2025.116164_bib29","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/ijgc-2024-005416","article-title":"Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial","volume":"34","author":"Bogani","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2025.116164_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2025.04.576","article-title":"Pattern of recurrence of the molecular subgroups in stage I high-grade endometrial cancer","volume":"197","author":"Leon-Castillo","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2025.116164_bib31","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/ijgc-2023-005058","article-title":"Prognostic value of molecular classification in stage IV endometrial cancer","volume":"34","author":"Uijterwaal","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2025.116164_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1200\/JCO-24-01887","article-title":"Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors","volume":"43","author":"Slomovitz","year":"2025","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2025.116164_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.annonc.2024.04.007","article-title":"MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy","volume":"35","author":"Pignata","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2025.116164_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102701","article-title":"Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis","volume":"125","author":"Bartoletti","year":"2024","journal-title":"Cancer Treat Rev"},{"issue":"23","key":"10.1016\/j.ejca.2025.116164_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13237041","article-title":"The role of immunotherapy in MMR-deficient endometrial carcinoma: state of the art and future perspectives","volume":"13","author":"Marchetti","year":"2024","journal-title":"J Clin Med"},{"issue":"18","key":"10.1016\/j.ejca.2025.116164_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16183221","article-title":"Low-risk and high-risk NSMPs: a prognostic subclassification of no specific molecular profile subtype of endometrial carcinomas","volume":"16","author":"Marchetti","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2025.116164_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2024.10.028","article-title":"Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer","volume":"192","author":"Vrede","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2025.116164_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100085","article-title":"Grade and estrogen receptor expression identify a subset of no specific molecular profile endometrial carcinomas at a very low risk of disease-specific death","volume":"36","author":"Jamieson","year":"2023","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.ejca.2025.116164_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1200\/JCO.23.02768","article-title":"Clinical and molecular characteristics of high-risk, recurrent, or metastatic endometrial cancer that is human epidermal growth factor receptor 2-low","volume":"43","author":"van Dijk","year":"2025","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2025.116164_bib40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/PGP.0000000000000806","article-title":"Defining substantial lymphovascular space invasion in endometrial cancer","volume":"41","author":"Peters","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ejca.2025.116164_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2024.01.046","article-title":"Prognostic value of three-tiered scoring system for lymph-vascular space invasion in endometrial cancer: a systematic review and meta-analysis","volume":"184","author":"Han","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2025.116164_bib42","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ijgc-2023-004289","article-title":"Improving Endometrial cancer assessment by combining the new techniqUe of GENomic profiling with surgical Extra uterIne disEase assessment (EUGENIE)","volume":"33","author":"Kasius","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2025.116164_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003111","article-title":"Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: a development and validation study","volume":"17","author":"Reijnen","year":"2020","journal-title":"PLoS Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925010500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925010500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:07:15Z","timestamp":1773882435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925010500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"alternative-id":["S0959804925010500"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116164","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical stage in the era of molecular profiling of endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116164"}}